Founded in 2014 and located in the vibrant Medtech ecosystem in Montpellier, France, Sim&Cure is a digital start-up focused on Improving patient outcome and physician experience of endovascular treatment by combining Digital Twin and AI Technologies. As new technologies progress through the medical network, S&C will help its partners to flatten the learning curve. Sim&Cure's philosophy focuses on driving innovation in the healthcare industry and helping to improve treatments strategies in order to secure patient care. Sim&Cure has won the prestigious i-Lab national contest twice in 2014 and 2015 and i-Nov in 2020. The start-up is backed by the Seed Fund IT-Translation and Elaia Partners Sim&Cure has established scientific and clinical collaborations with leading laboratories and hospitals around the world. Sim&Cure opened a subsidiary in US (NY) in July 2019. The company employs 50 people and anticipates a phase of strong growth.